Effects of Dexmedetomidine on the Pharmacokinetics of Dezocine, Midazolam and Its Metabolite 1-Hydroxymidazolam in Beagles by UPLC-MS/MS

OBJECTIVE: We developed and validated a sensitive and reliable UPLC-MS/MS method for simultaneous determination of dezocine (DEZ), midazolam (MDZ) and its metabolite 1-hydroxymidazolam (1-OH-MDZ) in beagle plasma and investigated the effect of dexmedetomidine (DEX) on the pharmacokinetics of DEZ, MD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wei, Li, Shuang-long, Zhao, Ti, Li, Le, Xing, Wen-bin, Qiu, Xiang-jun, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342499/
https://www.ncbi.nlm.nih.gov/pubmed/32753841
http://dx.doi.org/10.2147/DDDT.S254055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342499/
https://www.ncbi.nlm.nih.gov/pubmed/32753841
http://dx.doi.org/10.2147/DDDT.S254055

Ejemplares similares